Article
Brochure
Executive Resource
Insight Hub
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Explore U.S. life sciences trends in patents, clinical trials, private capital, M&A and public markets in the first half of 2026.
In a recent Medical Journal - Houston publication, David Lange explores how proposed SEC changes could make going public easier for life sciences firms.
Success StoryLearn how Weaver's independent valuation supported a fair market value determination in a multimillion-dollar health care ownership dispute.
Digital assets in partnerships create complex tax challenges. Learn how Section 704(c) applies and how to manage basis and allocations effectively.
The SBIR and STTR reauthorization brings larger awards, stricter eligibility and more competition for life sciences companies seeking federal funding.
Without active markets, digital asset valuation becomes complex. Understand ASU 2023-08, ASC 820 and key risks shaping fair value.
PodcastLearn why Texas is a leading life sciences hub, from workforce to funding. Discover what’s driving growth and what it means for companies.
New SEC-CFTC guidance clarifies how crypto assets are classified under U.S. law and when non‑security tokens may still fall under securities rules.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Passive loss rules can limit bitcoin mining tax benefits. Learn how Section 469, material participation and bonus depreciation affect deductions.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Explore key blockchain and digital asset trends that shaped 2025 and what regulation, infrastructure and adoption signal for 2026.
